Iradimed Corp.
- IRMD · Nasdaq
- Surgical & Medical Instruments & Apparatus
- Orlando, FL
- 166 employees
- CIK 0001325618
Updated from SEC filings through
Top things to know
Executives
- Roger E. Susi CEO, President, Chairman 4, 2026-06-02
- John Glenn CFO 4, 2026-06-23
- Jeff Chiprin Chief Commercial Officer 4, 2026-03-05
Iradimed Corp is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Orlando, FL. It trades as IRMD on Nasdaq. Revenue was $83.8M in the fiscal year ending December 31, 2025, +14.4% from the year before. It reported about 166 employees. Roger E. Susi is CEO, President, Chairman.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $83.8M 10-K, 2026-03-06 | $73.2M 10-K, 2026-03-06 | $65.6M 10-K/A, 2025-09-03 | $53.3M 10-K, 2024-03-01 | $41.8M 10-K, 2023-03-02 |
| Operating income | $26.1M 10-K, 2026-03-06 | $22.0M 10-K, 2026-03-06 | $20.0M 10-K/A, 2025-09-03 | $15.6M 10-K, 2024-03-01 | $9.8M 10-K, 2023-03-02 |
| SG&A | $35.2M 10-K, 2026-03-06 | $31.6M 10-K, 2026-03-06 | $27.3M 10-K/A, 2025-09-03 | $23.4M 10-K, 2024-03-01 | $20.3M 10-K, 2023-03-02 |
| Net income | $22.5M 10-K, 2026-03-06 | $19.2M 10-K, 2026-03-06 | $17.2M 10-K/A, 2025-09-03 | $12.8M 10-K, 2024-03-01 | $9.3M 10-K, 2023-03-02 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Roger E. Susi President at Iradimed Corp and Owner, Iradimed Corp | CEO, President, Chairman | 4, 2026-06-02 |
| Roger Susi | Board member (per proxy) bio: Chairman of the Board, President and Chief Executive Officer, Director, director nominee, and Chairman of the Board nominee | DEF 14A, 2026-04-30 |
| John Glenn | CFO | 4, 2026-06-23 |
| Jeff Chiprin | Chief Commercial Officer | 4, 2026-03-05 |
| Hilda Scharen-Guivel | Board member (per proxy) bio: Director and director nominee | DEF 14A, 2026-04-30 |
| James Hawkins | Board member (per proxy) bio: Director and director nominee | DEF 14A, 2026-04-30 |
| Joe Kiani | Board member (per proxy) bio: Director and director nominee | DEF 14A, 2026-04-30 |
| Monty Allen | Board member (per proxy) bio: Director and director nominee | DEF 14A, 2026-04-30 |
What Iradimed Corp does
IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 12.8 million (as of October 30, 2026) | 10-Q, October 30, 2026 |
|---|---|---|
| Public float | $481M (as of June 30, 2025) | 10-K, March 6, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, October 30, 2026 |
| Latest proxy statement | Meeting June 23, 2026 (filed April 30, 2026) | DEF 14A, April 30, 2026 |
| Auditor | Rsm Us LLP (Orlando, Florida) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 3, 2026 | Monty K. Allen Director | Sale | 1,419 | $123K | Form 4, September 8, 2026 |
| June 4, 2026 | Hilda Frederique Scharen-Guivel Director | Sale | 3,000 | $285K | Form 4, June 4, 2026 |
| June 1, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 2,500 | $227K | Form 4, June 2, 2026 |
| May 27, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 7,500 | $691K | Form 4, May 28, 2026 |
| May 19, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 7,500 | $657K | Form 4, May 20, 2026 |
| May 12, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 7,500 | $631K | Form 4, May 13, 2026 |
| May 5, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 7,500 | $643K | Form 4, May 6, 2026 |
| April 28, 2026 | Roger E. Susi CEO, President, Chairman | Sale | 7,500 | $658K | Form 4, April 30, 2026 |
Recent 8-K events
- 8-K filed 2026-10-30
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-31
- Item 8.01 Other events
- 8-K filed 2026-06-24
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-01
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-02-10
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-12-08
- Item 8.01 Other events
- 8-K filed 2025-11-03
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-09-02
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2025-08-01
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-06-23
- Item 5.07 Submission of matters to a vote of security holders
Frequently asked questions about Iradimed Corp
- What does Iradimed Corp do?
- In its own words, from Item 1 of its 10-K: "IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014."
- What is Iradimed Corp's revenue?
- $83.8M for the fiscal year ending December 31, 2025, from its 10-K filed March 6, 2026.
- Is Iradimed Corp profitable?
- Iradimed Corp reported net income of $22.5M for the fiscal year ending December 31, 2025.
- How many employees does Iradimed Corp have?
- About 166 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Iradimed Corp?
- Roger E. Susi, CEO, President, Chairman, as named in a 4 filed June 2, 2026.
- Who is the CFO of Iradimed Corp?
- John Glenn, CFO, as named in a 4 filed June 23, 2026.
- Where is Iradimed Corp headquartered?
- Orlando, FL.
- What is Iradimed Corp's stock ticker?
- IRMD on Nasdaq.
- What industry is Iradimed Corp in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Iradimed Corp's website?
- iradimed.com.
- When does Iradimed Corp report earnings next?
- January 29, 2027. Source: estimate_8k_pattern.
- Is Iradimed Corp a public company?
- Yes. Iradimed Corp files with the SEC under CIK 0001325618 and trades as IRMD.
- Who audits Iradimed Corp?
- Rsm Us LLP, Orlando, Florida, as named in its latest annual report (10-K).
- How many shares of Iradimed Corp are outstanding?
- 12.8 million shares as of October 30, 2026, from its 10-Q filed October 30, 2026.
- What is Iradimed Corp's public float?
- $481M as of June 30, 2025, as reported on the cover of its 10-K filed March 6, 2026.
- How many business segments does Iradimed Corp report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed October 30, 2026.
- When is Iradimed Corp's annual shareholder meeting?
- June 23, 2026, per its proxy statement (DEF 14A) filed April 30, 2026.
- Have Iradimed Corp insiders traded stock recently?
- Since November 20, 2025, officers and directors reported 30 open-market sales worth about $16.5M and 0 purchases on Forms 4 and 5. The most recent: Monty K. Allen (Director) sold 1,419 shares on September 3, 2026.